| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | AVANIR PHARMACEUTICALS INC CL | 250,000 | 1,410,000 | 0.66% | ||
| 52 | NEWLINK GENETICS CORP COM | 50,000 | 1,328,000 | 0.62% | ||
| 53 | DYAX CORP COM CVR | 117,500 | 1,128,000 | 0.53% | ||
| 54 | ACHAOGEN INC COM | 75,000 | 1,047,000 | 0.49% | ||
| 55 | Egalet Corp | 75,000 | 984,000 | 0.46% | ||
| 56 | ENTEROMEDICS INC | 600,000 | 936,000 | 0.44% | ||
| 57 | LA JOLLA PHARMACEUTICAL CO | 100,000 | 918,000 | 0.43% | ||
| 58 | SORRENTO THERAPEUTICS INC COM NEW | 130,000 | 878,000 | 0.41% | ||
| 59 | DEPOMED INC | 50,000 | 695,000 | 0.32% | Put | |
| 60 | FLEXION THERAPEUTICS INC | 50,000 | 674,000 | 0.31% | ||
| 61 | SUNSHINE HEART INC | 100,000 | 560,000 | 0.26% | ||
| 62 | SUNSHINE HEART INC | 75,000 | 420,000 | 0.20% | Call | |
| 63 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 25,000 | 375,000 | 0.17% | ||
| 64 | MAST THERAPEUTICS INC COM | 500,000 | 315,000 | 0.15% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001597549-14-000004, filed 2014.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
